When SARS-CoV-2 binds to the ACE2 receptor, the ACE2 pathway is activated, causing acute ß-cell dysfunction and leading to a hyperglycemic state, which may increase the severity of GDM or promote the de novo onset of GDM [33,35,48]. This evidence concerns the gene ACE2 and gestational diabetes.